Historical Stock Price
THRX historical stock prices picture
Theseus Pharmaceuticals (THRX) has the following price history information. Looking back at THRX historical stock prices for the last five trading days, on February 08, 2024, THRX opened at $4.08, traded as high as $4.09 and as low as $4.06, and closed at $4.06. Trading volume was a total of 327.40K shares. On February 09, 2024, THRX opened at $4.07, traded as high as $4.09 and as low as $4.07, and closed at $4.07. Trading volume was a total of 122.00K shares. On February 12, 2024, THRX opened at $4.07, traded as high as $4.08 and as low as $4.06, and closed at $4.06. Trading volume was a total of 231.10K shares. On February 13, 2024, THRX opened at $4.06, traded as high as $4.07 and as low as $4.06, and closed at $4.06. Trading volume was a total of 3.12M shares. On February 14, 2024, THRX opened at $4.06, traded as high as $4.06 and as low as $4.06, and closed at $4.06. Trading volume was a total of 0 shares.

THRX Historical Stock Prices By Date:

THRX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Theseus Pharmaceuticals shares, starting with a $10,000 purchase of THRX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/07/2021
End date: 02/14/2024
Start price/share: $18.58
End price/share: $4.06
Dividends collected/share: $0.00
Total return: -78.15%
Average Annual Total Return: -47.56%
Starting investment: $10,000.00
Ending investment: $2,185.14
Years: 2.36
Date Open High Low Close Volume
02/08/2024 $4.08 $4.09 $4.06 $4.06 327.40K
02/09/2024 $4.07 $4.09 $4.07 $4.07 122.00K
02/12/2024 $4.07 $4.08 $4.06 $4.06 231.10K
02/13/2024 $4.06 $4.07 $4.06 $4.06 3.12M
02/14/2024 $4.06 $4.06 $4.06 $4.06 0
Theseus Pharmaceuticals is engaged in the discovery, development and commercialization of targeted therapies for cancer patients. Co.'s development programs are designed to address drug resistance mutations in key driver oncogenes. Co.'s product candidate, THE-630, is a pan-variant inhibitor of all main classes of activating and resistance mutations of the KIT kinase for the treatment of gastrointestinal stromal tumours. Co.'s second program is focused on inhibitors of epidermal growth factor receptor (EGFR), that are active against C797S, the common EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer.
Date Close
02/08/2024$4.06
02/09/2024$4.07
02/12/2024$4.06
02/13/2024$4.06
02/14/2024$4.06
THRX is categorized under the Healthcare sector; below are some other companies in the same sector:

TKAI Historical Stock Prices
TKMR Historical Stock Prices
TLB Historical Stock Prices
TLGT Historical Stock Prices
TLOG Historical Stock Prices
TMO Historical Stock Prices
TNDM Historical Stock Prices
TNXP Historical Stock Prices
TOCA Historical Stock Prices
TOS Historical Stock Prices

Email EnvelopeFree THRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


THRX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.